Sihuan Pharmaceutical Holdings Group (HKSE:00460) EPS (Basic) : HK$-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group EPS (Basic)?

Sihuan Pharmaceutical Holdings Group's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was HK$-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.01.

Sihuan Pharmaceutical Holdings Group's EPS (Diluted) for the six months ended in Dec. 2023 was HK$-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.01.

Sihuan Pharmaceutical Holdings Group's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sihuan Pharmaceutical Holdings Group's highest 3-Year average EPS without NRI Growth Rate was 63.00% per year. The lowest was -35.50% per year. And the median was 27.30% per year.

Sihuan Pharmaceutical Holdings Group EPS (Basic) Historical Data

The historical data trend for Sihuan Pharmaceutical Holdings Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sihuan Pharmaceutical Holdings Group EPS (Basic) Chart

Sihuan Pharmaceutical Holdings Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.32

0.06

0.05

-0.23

-0.01

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.03	0.01	-0.23	-0.01	-

Sihuan Pharmaceutical Holdings Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sihuan Pharmaceutical Holdings Group's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-59.083	-	0)	/	9297.073
	=	-0.01

Sihuan Pharmaceutical Holdings Group's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-4.783	-	0)	/	9281.135
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.01

Sihuan Pharmaceutical Holdings Group (HKSE:00460) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sihuan Pharmaceutical Holdings Group EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sihuan Pharmaceutical Holdings Group (HKSE:00460) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (HKSE:00460) » Definitions » EPS (Basic)

Traded in Other Exchanges

SHPHF:USA

Address

Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025

Website

https://www.sihuanpharm.com

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.

Executives

Che Fengsheng	2201 Interest of corporation controlled by you
Guo Weicheng	2201 Interest of corporation controlled by you
Meng Xianhui	2201 Interest of corporation controlled by you
Zhang Jionglong	2201 Interest of corporation controlled by you
Mingyao Capital Limited	2401 A concert party to an agreement to buy shares
Network Victory Limited	2401 A concert party to an agreement to buy shares
Proper Process International Limited	2401 A concert party to an agreement to buy shares
Successmax Global Holdings Limited	2101 Beneficial owner
Victory Faith International Limited	2401 A concert party to an agreement to buy shares
Ubs Tc (jersey) Ltd	2301 Trustee
Ubs Trustees (cayman) Ltd.	2301 Trustee
Smart Top Overseas Limited	2501 Other
Plenty Gold Enterprises Limited	2307 Founder of a discretionary trust who can infl

Sihuan Pharmaceutical Holdings Group (HKSE:00460) Headlines

No Headlines